These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11741371)

  • 1. 'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy.
    Kuhn H; Gietzen F; Leuner C
    Eur Heart J; 2002 Jan; 23(1):91-3. PubMed ID: 11741371
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-surgical myocardial ablation: for hypertrophic obstructive cardiomyopathy.
    Sigwart U
    Cardiologia; 1998 Feb; 43(2):157-61. PubMed ID: 9557371
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy.
    Keren A; Banai S
    Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983
    [No Abstract]   [Full Text] [Related]  

  • 4. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.
    Jaffe R; Charron T; Puley G; Dick A; Strauss BH
    Circulation; 2008 Jun; 117(24):3152-6. PubMed ID: 18559715
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous transluminal catheter-based coil embolization of septal artery as a treatment for hypetrophic obstructive cardiomyopathy.
    Vaishnav S; Gautam N
    Indian Heart J; 2007; 59(2):195-6. PubMed ID: 19122258
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of coronary flow reserve].
    Kuhn H
    Internist (Berl); 1998 Feb; 39(2):217. PubMed ID: 9556738
    [No Abstract]   [Full Text] [Related]  

  • 7. Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
    Yip HK; Chen MC; Chang HW; Kuo FY; Yang CH; Chen SM; Hung WC; Chen CJ; Cheng CI; Wu CJ
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):503-11. PubMed ID: 15065147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323
    [No Abstract]   [Full Text] [Related]  

  • 9. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed response following trans-catheter coil embolization in HOCM.
    Math RS; Singh S; Seth S; Shankar B; Bhargava B; Sharma S; Gulati G
    Indian Heart J; 2007; 59(4):383-5. PubMed ID: 19126951
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment of coronary microvascular flow in hypertrophic cardiomyopathy.
    Dimitrow PP; Dubiel JS
    Eur Heart J; 2002 Jun; 23(12):991. PubMed ID: 12069455
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in cardiology.
    Forman DE; Gordon PC; Parisi AF
    Med Health R I; 1996 May; 79(5):165-74. PubMed ID: 8665430
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
    Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 16. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
    Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of coronary flow reserve].
    Strauer BE
    Internist (Berl); 1998 Nov; 39(11):1196-8. PubMed ID: 9859058
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S; Makkar R
    Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.